Observational Study
Copyright ©The Author(s) 2020.
World J Hepatol. Jun 27, 2020; 12(6): 312-322
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.312
Table 1 Patients’ characteristics at diagnosis
General characteristics
Median age (yr)37 ± 11.8(26–67)n = 24
Gender: Male14(58)n = 24
Median BMI (kg/m2)24 ± 4.5(18.9–34)n = 24
Pregnancy at diagnosis0(0)n = 10
Ethnicityn = 24
Caucasian12(50)
Maghrebian10(42)
Asian1(4)
Sub-Saharan African1(4)
Medical history
Acute pancreatitis13(54)n = 24
Cholecystectomy10(42)n = 24
Family history of cholelithiasis in first-degree relatives7(30)n = 23
Acute cholecystitis3(13)n = 24
Acute cholangitis3(13)n = 24
Chronic pancreatitis0(0)n = 24
Cholestasis of pregnancy0(0)n = 10
Estrogen therapy0(0)n = 10
Existing medical conditions
Recurring pain21(88)n = 24
Acute pancreatitis9(38)n = 24
Acute cholecystitis2(14)n = 14
Acute cholangitis1(4)n = 24
Cytolysisn = 23
Presence13(57)
Quantification (N)2.8 ± 3.1(0–10)
Cholestasisn = 23
Presence13(57)
Quantification (N)1.7 ± 2.0(0–8)
Table 2 Radiological features unveiled during ultrasound examinations
Intrahepatic bile duct findingsn = 24
Comet-tail artifacts23(96)
Microlithiasis20(83)
Acoustic shadows17(71)
Stones3(13)
Associated findings
Gallstones6(43)n = 14
Gallbladder sludge2(14)n = 14
Gallbladder hydrops1(7)n = 14
Common bile duct stones1(4)n = 23
Table 3 Patients’ characteristics during follow-up
Follow-up time (mo)19.7 ± 5.8(10.1–29.4)n = 24
Patients’ care
Hospitalization
In a conventional care unit
Yes18(75)n = 24
Duration (days)6.8 ± 3.1(2–14)n = 18
In an intensive care unit0(0)n = 24
Treatment
UDCA18(75)n = 24
Cholecystectomy5(36)n = 14
Outcome
Good adherence to UDCA12(67)n = 18
UDCA efficacy17(94)n = 18
Onset of action (in weeks)3.4 ± 2.5(2–12)n = 17
Pain recurrence5(28)n = 18
UDCA intolerance2(11)n = 18
Death0(0)n = 24